Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial

Sofia Pazmino,Delphine Bertrand,Annelies Boonen,René Westhovens,Veerle Stouten,Johan Joly,Diederik De Cock,Patrick Verschueren

doi:10.1136/rmdopen-2021-001615

Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial

Sofia Pazmino, Delphine Bertrand + Show 6 more

Open Access

https://doi.org/10.1136/rmdopen-2021-001615

Copy DOI

Journal: RMD Open	Publication Date: May 1, 2021
Citations: 17	License type: open-access

Affiliation: KU Leuven, Maastricht University Medical Centre, Maastricht University, Universitair Ziekenhuis Leuven

#COBRA Slim #Early Rheumatoid Arthritis + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectiveTo explore non-steroidal anti-inflammatory drug (NSAID) and analgesic use in early rheumatoid arthritis (eRA) patients with a favourable risk profile initiating methotrexate (MTX) with or without glucocorticoid (GC) bridging.MethodsPatients with...

Full Text